Epidemic Infections in Bioterrorism

182 Epidemic Infections in Bioterrorism





Perspective*


Biologic agents have the potential to cause as many casualties in a densely populated area as a nuclear weapon. If used in a terrorist attack on civilian populations, biologic weapons could also result in widespread social disruption and complete exhaustion of health care resources.1,57


The Centers for Disease Control and Prevention (CDC) classified the major bioterrorist threats into three categories, based on the overall danger to the American public.8 Category A agents are the most easily weaponized and disseminated, cause the highest mortality, produce extensive social disruption, and require special public health preparedness systems. Category B agents do not cause as high mortality as category A agents, but they still result in considerable morbidity and require enhancement of current surveillance systems. Category C agents are the third-highest priority and comprise new and emerging agents that are concerning because of their potential to cause significant morbidity. The list of category A, B, and C agents is given in Table 182.1.



Bioterrorism agents are most dangerous to humans when these agents are in aerosolized form.6 Particles smaller than 10 mcg effectively reach the alveoli. Certain agents (e.g., anthrax, botulinum) are more resistant to environmental degradation than others (e.g., plague). Some agents (e.g., plague, smallpox) may be transmitted from person to person, thus causing high rates of dissemination and requiring strict isolation measures. Until biologic contaminants are excluded, pulmonary isolation measures should be instituted in all these patients. At present, only anthrax and smallpox have vaccines licensed by the U.S. Food and Drug Administration, and both vaccines require complex administration schedules.9


Surveillance and management protocols should be instituted at the hospital level for dealing with large numbers of patients who present with respiratory complaints over a short period of time. If surveillance methods do indicate a bioterrorist attack, the community must work to prevent widespread contamination, to help curb the strain on health care resources. A joint report by the CDC and the U.S. Department of Health and Human Services in February 2007 established guidelines to limit the spread of a pandemic infection.10 Measures such as the recommendation that ill individuals stay home from work or school, cancellation of large public gatherings, and the use of strict hygiene techniques in the workplace could help avert a health care crisis.



Anthrax


Anthrax is caused by Bacillus anthracis, a gram-positive, aerobic, spore-forming bacillus. It is considered to be the biologic agent most likely to be used in a terrorist attack. A bioterrorist attack with powder containing anthrax spores in the United States in 2001 resulted in 22 confirmed cases. The bacteria are simple to obtain and grow. The resulting spores can be aerosolized, are extremely resistant to environmental degradation, and can cause untreated mortality rates up to 50% in exposed individuals. A 1970 World Health Organization study estimated that 50 kg of anthrax spores released in a city with half a million people could cause almost 100,000 deaths.


Anthrax causes cutaneous, gastrointestinal, and pulmonary disease. Human infection, usually cutaneous, typically occurs naturally from exposure to domesticated farm animals, such as sheep and cattle. Cutaneous anthrax is responsible for more than 90% of naturally occurring infections. It initially manifests as an erythematous patch, followed by degeneration into necrotic cellulitis with black eschar similar to a brown recluse spider bite. Gastrointestinal anthrax is extremely rare and causes hemorrhagic gastroenteritis and systemic toxicity.



Inhaled anthrax, the bioterrorist threat, causes the highest mortality of all the forms of anthrax. The clinical syndrome is divided into three phases, none exhibiting findings that would allow a clinician to identify the disease definitively. The first phase mimics a nonspecific viral syndrome and is followed by the second phase, which is a 2-day recovery period. The third phase resembles severe bacterial pneumonia, with sudden onset of fever, chills, cough, dyspnea, and respiratory failure. Hematogenous spread can cause meningitis and necrotizing enteritis. Results of common laboratory tests may be abnormal, but all these tests lack sufficient sensitivity and specificity. Chest radiographs characteristically show mediastinal widening consistent with hemorrhagic mediastinitis. Computed tomography has better sensitivity for mediastinal lymphadenopathy and should be performed in suspected cases when radiographs are normal.



image Priority Actions



















Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Epidemic Infections in Bioterrorism

Full access? Get Clinical Tree

Get Clinical Tree app for offline access
Problem Action
Respiratory distress? Have a low threshold for intubation in these patients. Respiratory failure and hypoxemia can occur rapidly. Always wear a mask while intubating and use rapid-sequence induction to minimize coughing.
Septic shock? Institute early goal-directed therapy with fluids, vasoactive agents, antibiotics, and hemodynamic monitoring.
Neuromuscular weakness? Obtain a vital capacity early in patients with botulism.Diaphragmatic weakness quickly leads to respiratory failure.
Potential for spread to health care workers?